SEIZURE IN PARTICIPANTS WITH LENNOX-GASTAUT SYNDROME

Clinical trials for SEIZURE IN PARTICIPANTS WITH LENNOX-GASTAUT SYNDROME explained in plain language.

Never miss a new study

Get alerted when new SEIZURE IN PARTICIPANTS WITH LENNOX-GASTAUT SYNDROME trials appear

Sign up with your email to follow new studies for SEIZURE IN PARTICIPANTS WITH LENNOX-GASTAUT SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

CBD tested in infants with rare, severe seizure disorders

Disease control Terminated

This study aimed to test the safety and effectiveness of a cannabidiol (CBD) oral solution in babies under 2 years old with severe, hard-to-control epilepsy syndromes. It was designed to see if adding CBD to their current medications could help reduce their seizures. The study wa…

Matched conditions: SEIZURE IN PARTICIPANTS WITH LENNOX-GASTAUT SYNDROME

Phase: PHASE3 • Sponsor: Jazz Pharmaceuticals • Aim: Disease control

Last updated Mar 30, 2026 14:31 UTC

SEIZURE IN PARTICIPANTS WITH LENNOX-GASTAUT SYNDROME

Get alerted when new SEIZURE IN PARTICIPANTS WITH LENNOX-GASTAUT SYNDROME trials appear

CBD tested in infants with rare, severe seizure disorders